Last reviewed · How we verify
Suprane (DESFLURANE)
At a glance
| Generic name | DESFLURANE |
|---|---|
| Sponsor | Baxter |
| Drug class | General Anesthetic [EPC] |
| Target | GABA-A receptor; anion channel |
| Modality | Small molecule |
| Therapeutic area | Neuroscience |
| Phase | FDA-approved |
| First approval | 1992 |
Approved indications
- General anesthesia
Common side effects
- Coughing
- breathholding
- apnea
- Nausea
- vomiting
Drug interactions
- amfepramone
- amfetamine
- benzphetamine
- dexamfetamine
- dexmethylphenidate
- dobutamine
- ephedrine
- epinephrine
- formoterol
- indacaterol
- isometheptene
- isoprenaline
Key clinical trials
- Effect of Sevoflurane vs Desflurane on Mechanical Power in Laparoscopic Cholecystectomy (NA)
- General Anesthesia and General Anesthesia Combined With Thoracic Epidural Anesthesia (NA)
- Desflurane Versus Isoflurane for Speeding Postanesthetic Recovery and Hospital Discharge (NA)
- Anesthesia on Optic Nerve Sheath Diameter (NA)
- Low-Flow Desflurane vs Sevoflurane: Impact on Physiology and Recoveryand Recovery Profiles in Adult ENT Surgery (NA)
- Low-Flow Sevoflurane and Desflurane Anesthesia in Laparoscopic Cholecystectomy (NA)
- Opioid-Free vs Opioid-Based Anesthesia in Bariatric Surgery (NA)
- The Effect of the Anticholinergic Burden Following Elective Coronary Artery Surgery (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |